These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35850645)

  • 1. OTUB2 Regulates YAP1/TAZ to Promotes the Progression of Esophageal Squamous Cell Carcinoma.
    Liu L; Cheng H; Ji M; Su L; Lu Z; Hu X; Guan Y; Xiao J; Ma L; Zhang W; Pu H
    Biol Proced Online; 2022 Jul; 24(1):10. PubMed ID: 35850645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of YAP1 and TAZ in esophageal squamous cell carcinoma.
    Liu L; Lu Z; Hu X; Su T; Su L; Pu H
    Medicine (Baltimore); 2021 Jul; 100(28):e26597. PubMed ID: 34260541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway.
    Ma L; Liu L; Ji M; Su L; Guan Y; Xiao J; Pu H
    Open Life Sci; 2023; 18(1):20220743. PubMed ID: 37791063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEK2 promotes the migration and proliferation of ESCC via stabilization of YAP1 by phosphorylation at Thr-143.
    Su W; Hu H; Ding Q; Wang M; Zhu Y; Zhang Z; Geng Z; Lin S; Zhou P
    Cell Commun Signal; 2022 Jun; 20(1):87. PubMed ID: 35705994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-34a-5p Inhibits Proliferation, Migration, Invasion and Epithelial-mesenchymal Transition in Esophageal Squamous Cell Carcinoma by Targeting LEF1 and Inactivation of the Hippo-YAP1/TAZ Signaling Pathway.
    Wang X; Zhao Y; Lu Q; Fei X; Lu C; Li C; Chen H
    J Cancer; 2020; 11(10):3072-3081. PubMed ID: 32226522
    [No Abstract]   [Full Text] [Related]  

  • 6. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma.
    Kuo YZ; Kang YR; Chang WL; Sim LC; Hsieh TC; Chang CH; Wang YC; Tsai CJ; Huang LC; Tsai ST; Wu LW
    Cell Oncol (Dordr); 2022 Oct; 45(5):893-909. PubMed ID: 35930163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Arginine Methyltransferase 5 Promotes Esophageal Squamous Cell Carcinoma Proliferation and Metastasis via LKB1/AMPK/mTOR Signaling Pathway.
    Chen YR; Li HN; Zhang LJ; Zhang C; He JG
    Front Bioeng Biotechnol; 2021; 9():645375. PubMed ID: 34124017
    [No Abstract]   [Full Text] [Related]  

  • 9. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H
    Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and function of circular RNA hsa_circ_0071106: A novel biomarker for differentiation degree of esophageal squamous cell carcinoma.
    Tang Y; Gao Z; Liu R
    Pathol Res Pract; 2022 May; 233():153875. PubMed ID: 35390631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
    Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
    Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SERPINE2 promotes cellular migration and invasion in esophageal squamous cell carcinoma by activating β-catenin].
    Zhang JL; Luo AP; Huang FR; Gong TY; Liu ZH
    Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):638-645. PubMed ID: 34289555
    [No Abstract]   [Full Text] [Related]  

  • 13. Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma.
    Wang C; Cheng L; Song S; Wu S; Sun G
    J Cell Physiol; 2020 Nov; 235(11):8224-8235. PubMed ID: 31957872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.
    Huang J; Yang J; Zhang Y; Lu D; Dai Y
    Exp Cell Res; 2023 Jun; 427(1):113585. PubMed ID: 37030332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma.
    Zeng YZ; Zhang YQ; Chen JY; Zhang LY; Gao WL; Lin XQ; Huang SM; Zhang F; Wei XL
    Front Oncol; 2021; 11():627713. PubMed ID: 33854967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COQ10B Knockdown Modulates Cell Proliferation, Invasion, Migration, and Apoptosis in Esophageal Squamous Cell Carcinoma.
    Wei Y; Liu J; Gao Y; Ma X; Cao L; Maimaitiming N; Qu C; Zhang L
    Evid Based Complement Alternat Med; 2022; 2022():6247824. PubMed ID: 35911165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
    Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y
    BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth Differentiation Factor 15 Promotes Progression of Esophageal Squamous Cell Carcinoma via TGF-β Type II Receptor Activation.
    Okamoto M; Koma YI; Kodama T; Nishio M; Shigeoka M; Yokozaki H
    Pathobiology; 2020; 87(2):100-113. PubMed ID: 31896114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NEK2 promotes the migration, invasion, proliferation of ESCC and mediates ESCC immunotherapy.
    Gu S; Yasen Y; Wang M; Huang B; Zhou Y; Wang W
    Heliyon; 2024 May; 10(9):e29682. PubMed ID: 38707418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIF Inhibits Proliferation of Esophageal Squamous Carcinoma Cells by Radiation Mediated Through JAK-STAT Signaling Pathway.
    Luo H; Yang Z; Zhang Q; Li T; Liu R; Feng S; Liu Z; Sun S; Chen J; Wang X; Xie X
    J Cancer; 2023; 14(4):532-543. PubMed ID: 37057285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.